San Diego, CA, United States of America

Russell Mcdaniel

This inventor holds 1 USPTO granted patent. Top assignee: Carefusion 303, Inc.. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Russell McDaniel

Introduction

Russell McDaniel is a notable inventor based in San Diego, CA. He has made significant contributions to the field of drug library management through his innovative patent. His work focuses on improving the efficiency of managing versioned libraries, which is crucial in various applications, particularly in the pharmaceutical industry.

Latest Patents

Russell McDaniel holds a patent titled "Efficient storage of drug library editor entries." This patent outlines systems and methods that provide an efficient solution for managing entries of versioned libraries. The method involves receiving requests to modify entries, obtaining snapshot records, and generating updated records that capture user changes. This innovation enhances the management of drug libraries by ensuring that version identification values are accurately maintained.

Career Highlights

Russell McDaniel is associated with CareFusion 303, Inc., where he applies his expertise in developing solutions for drug management systems. His work has contributed to advancements in the efficiency and reliability of pharmaceutical data management.

Collaborations

Some of his notable coworkers include Richard Anthony Parr and Andrew S. Ergeson. Their collaboration has likely fostered an environment of innovation and creativity, leading to impactful developments in their field.

Conclusion

Russell McDaniel's contributions to the field of drug library management through his patent demonstrate his commitment to innovation. His work not only enhances the efficiency of managing pharmaceutical data but also reflects the importance of collaboration in driving advancements in technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…